search
Back to results

Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies

Primary Purpose

Prolonged Pregnancy

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Mechanical cervical ripening
Pharmacological cervical ripening
Sponsored by
University Hospital, Tours
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Prolonged Pregnancy focused on measuring prolonged pregnancy, mechanical cervical ripening

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Pregnant women
  • ≥ 18 years old
  • With a singleton cephalic pregnancy between ≥41+0 weeks and ≤ 42+0 weeks of gestation
  • Gestational age estimated from the first trimester ultrasound (realized between 11 and 13+6 weeks of gestation)
  • With a decision of induction of labour
  • Written informed consent obtained from subject
  • Subject covered by or having the rights to the French Social Security system

Exclusion Criteria:

  • Bishop score ≥ 6 (favourable cervix)
  • Non cephalic presentation (breech, transverse)
  • Severe preeclampsia defined as the presence of preeclampsia with at least one of the following items :

    • Severe maternal hypertension (systolic blood pressure ≥ 160 mm Hg and/or diastolic blood pressure ≥ 110 mm Hg)
    • Renal failure with oliguria (< 500 ml/24h) or creatinine > 135μmol/L, or proteinuria > 5 g/day
    • Pulmonary oedema, epigastric pain or HELLP syndrom (hemolysis, elevated liver enzyme, low platelets)
    • Eclampsia or neurologic persisting symptoms (visual disturbances, headache, increased reflexes)
    • Thrombopenia < 100 G/L
  • Prior caesarean section or uterine scar
  • Placenta praevia
  • Suspected genital herpes infection
  • Known VIH seropositivity (confirmed by blood serology)
  • Premature rupture of membranes (PROM - continual leaking of amniotic fluid or positive test in favour of PROM)
  • Foetus with suspected severe congenital abnormalities
  • Pathological fetal heart rate
  • Contra-indications to Propess®
  • Contra-indications for using Cook® Cervical Ripening Balloon
  • Women under guardianship or trusteeship

Sites / Locations

  • Chu Brest
  • CHU CAEN
  • Ch Pontoise
  • Ch Chartres
  • Chu Clermont-Ferrand
  • Ch Departemental Vendee
  • Hopital Saint Joseph
  • Chu Nantes
  • Chi Poissy
  • Chu Reims
  • Chu Rennes
  • Chu Saint Etienne
  • Chu Toulouse
  • Chru Tours

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Mechanical cervical ripening

Pharmacological cervical ripening

Arm Description

mechanical cervical ripening with a Cook® Cervical Ripening Balloon

pharmacological cervical ripening with a 10mg slow releasing system of Dinoprostone (Propess®)

Outcomes

Primary Outcome Measures

Caesarean section rate for non-reassuring fetal status.
Indication of the caesarean section will be settled by an adjudication committee at the end of the study

Secondary Outcome Measures

Time between cervical ripening and delivery in hours
Evaluation of time between cervical ripening and delivery in hours
Delivery rate after 12 and 24 hours of cervical ripening
Evaluation of delivery rate after 12 and 24 hours of cervical ripening
Induction with oxytocin
yes/no
Total dose of oxytocin required for induction of labour
evaluation of total dose of oxytocin required for induction of labour
Uterine hyper stimulation defined as more than 6 contractions by 10 minutes over a 30 minutes period
uterine hyperstimulation
Requirement for tocolysis during cervical ripening or during labour
requirement for tocolysis
Suspicious or pathological fetal heart rate
FIGO classification
Uterine rupture
yes/no
Use of analgesics during labour
yes/no
Use of antibiotics during labour
yes/no
Indication for caesarean delivery other than non-reassuring FHR
(failure to progress in first or second stage of labour or maternal indication)
Type of vaginal delivery
spontaneous or instrumental, indication for instrumental delivery
Maternal intra partum infection
Suspicion of maternal intra partum infection
Maternal post partum infection
Suspicion of post partum infection
Maternal post partum haemorrhage
Post partum haemorrhage defined as estimated blood loss > 500 cc
Maternal blood transfusion
Blood transfusion
Neonatal apgar score
Apgar score at 1, 3, 5 and 10 minutes
Neonatal arterial ph
Arterial pH at delivery
Intensive care unit for newborn
Admission in an intensive care unit
Neonatal respiratory insufficiency
Respiratory insufficiency with necessity of any respiratory support
Birth asphyxia
Birth asphyxia defined as pH<7, Base Excess >12 mmol/l and encephalopathy.

Full Information

First Posted
September 6, 2016
Last Updated
September 25, 2019
Sponsor
University Hospital, Tours
search

1. Study Identification

Unique Protocol Identification Number
NCT02907060
Brief Title
Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies
Official Title
Propess® Versus Double Balloon for Cervical Ripening of Prolonged Pregnancies: a Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
January 27, 2017 (Actual)
Primary Completion Date
December 12, 2018 (Actual)
Study Completion Date
December 12, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Tours

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A pregnancy is considered ''prolonged'' from 41 weeks of gestation. Prolonged Pregnancies (PP) are associated with increased maternal morbidity: emergency caesarean, 3rd and 4th degree perineal lesions and postpartum haemorrhage. Foetuses are at increased risk of oligohydramnios, meconium-staining and Fetal Heart Rate (FHR) anomalies. Around 15% of all pregnancies are prolonged. A Cochrane review on induction of labour showed that a policy of labour induction at or beyond 41 weeks was associated with significantly fewer perinatal deaths. Thus the French College of Obstetricians and Gynaecologists stated, "induction of labour can be proposed to patients between 41+0 and 41+6 weeks of gestation". In cases where labour is induced and cervix is unfavourable, cervical ripening is advised. Methods of cervical ripening include pharmacological (prostaglandins) and mechanical (Foley catheter or trans-cervical double balloon) methods. Those two methods were compared in the PROBAAT trial among women with term pregnancies (beyond 37+0). The rates of caesarean section with these two strategies were identical, however uterine hyper stimulation with FHR anomalies occurred less when cervical ripening was mechanical. Considering pharmacological cervical ripening is associated with more uterine hyper stimulation and more FHR anomalies, it may not be the most appropriate in cases of fragile foetuses that include cases of prolonged pregnancies. Considering prolonged pregnancies are associated with a risk of FHR anomalies and that cervical ripening with a pharmacological method is another factor which increases this risk: women with prolonged pregnancies could benefit from a more "gentle" cervical ripening. At present, no particular method is recommended in cases of cervical ripening and prolonged pregnancies. We hypothesise that, in cases of prolonged pregnancies, mechanical cervical ripening, with less uterine hyperstimulation and fewer FHR anomalies, could be more appropriate and could reduce the rate of caesarean section for suspicion of fetal distress.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prolonged Pregnancy
Keywords
prolonged pregnancy, mechanical cervical ripening

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1224 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Mechanical cervical ripening
Arm Type
Experimental
Arm Description
mechanical cervical ripening with a Cook® Cervical Ripening Balloon
Arm Title
Pharmacological cervical ripening
Arm Type
Active Comparator
Arm Description
pharmacological cervical ripening with a 10mg slow releasing system of Dinoprostone (Propess®)
Intervention Type
Device
Intervention Name(s)
Mechanical cervical ripening
Intervention Description
The mechanical cervical ripening is a double transcervical balloon. The device used in the study is the Cook® Cervical Ripening Balloon with CE marked (commercialized by the Cook® laboratory, ref JCRBS-184000). It is a silicone double balloon catheter. Maximum balloon inflation is 80 mL/balloon. It will be used in accordance with user manual
Intervention Type
Drug
Intervention Name(s)
Pharmacological cervical ripening
Intervention Description
The comparative pharmacological procedure is a vaginal slow releasing system of dinoprostone. The form used in the study is Propess (Ferring pharmaceuticals) containing 10mg of dinoprostone (prostaglandin E2). It will be used in accordance with Summary of Product Characteristics
Primary Outcome Measure Information:
Title
Caesarean section rate for non-reassuring fetal status.
Description
Indication of the caesarean section will be settled by an adjudication committee at the end of the study
Time Frame
Up to 2 days after cervical ripening
Secondary Outcome Measure Information:
Title
Time between cervical ripening and delivery in hours
Description
Evaluation of time between cervical ripening and delivery in hours
Time Frame
Up to 2 days after cervical ripening
Title
Delivery rate after 12 and 24 hours of cervical ripening
Description
Evaluation of delivery rate after 12 and 24 hours of cervical ripening
Time Frame
up to 2 days after cervical ripening
Title
Induction with oxytocin
Description
yes/no
Time Frame
up to 2 days after cervical ripening
Title
Total dose of oxytocin required for induction of labour
Description
evaluation of total dose of oxytocin required for induction of labour
Time Frame
up to 2 days after cervical ripening
Title
Uterine hyper stimulation defined as more than 6 contractions by 10 minutes over a 30 minutes period
Description
uterine hyperstimulation
Time Frame
up to 2 days after cervical ripening
Title
Requirement for tocolysis during cervical ripening or during labour
Description
requirement for tocolysis
Time Frame
up to 2 days after cervical ripening
Title
Suspicious or pathological fetal heart rate
Description
FIGO classification
Time Frame
up to 2 days after cervical ripening
Title
Uterine rupture
Description
yes/no
Time Frame
up to 2 days after cervical ripening
Title
Use of analgesics during labour
Description
yes/no
Time Frame
up to 2 days after cervical ripening
Title
Use of antibiotics during labour
Description
yes/no
Time Frame
up to 2 days after cervical ripening
Title
Indication for caesarean delivery other than non-reassuring FHR
Description
(failure to progress in first or second stage of labour or maternal indication)
Time Frame
up to 2 days after cervical ripening
Title
Type of vaginal delivery
Description
spontaneous or instrumental, indication for instrumental delivery
Time Frame
up to 2 days after cervical ripening
Title
Maternal intra partum infection
Description
Suspicion of maternal intra partum infection
Time Frame
up to 2 days after cervical ripening
Title
Maternal post partum infection
Description
Suspicion of post partum infection
Time Frame
up to 2 days after cervical ripening
Title
Maternal post partum haemorrhage
Description
Post partum haemorrhage defined as estimated blood loss > 500 cc
Time Frame
up to 2 days after cervical ripening
Title
Maternal blood transfusion
Description
Blood transfusion
Time Frame
up to 2 days after cervical ripening
Title
Neonatal apgar score
Description
Apgar score at 1, 3, 5 and 10 minutes
Time Frame
at 1, 3, 5 and 10 minutes after delivery
Title
Neonatal arterial ph
Description
Arterial pH at delivery
Time Frame
at delivery
Title
Intensive care unit for newborn
Description
Admission in an intensive care unit
Time Frame
up to 5 days after cervical ripening
Title
Neonatal respiratory insufficiency
Description
Respiratory insufficiency with necessity of any respiratory support
Time Frame
up to 5 days after cervical ripening
Title
Birth asphyxia
Description
Birth asphyxia defined as pH<7, Base Excess >12 mmol/l and encephalopathy.
Time Frame
up to 5 days after cervical ripening

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant women ≥ 18 years old With a singleton cephalic pregnancy between ≥41+0 weeks and ≤ 42+0 weeks of gestation Gestational age estimated from the first trimester ultrasound (realized between 11 and 13+6 weeks of gestation) With a decision of induction of labour Written informed consent obtained from subject Subject covered by or having the rights to the French Social Security system Exclusion Criteria: Bishop score ≥ 6 (favourable cervix) Non cephalic presentation (breech, transverse) Severe preeclampsia defined as the presence of preeclampsia with at least one of the following items : Severe maternal hypertension (systolic blood pressure ≥ 160 mm Hg and/or diastolic blood pressure ≥ 110 mm Hg) Renal failure with oliguria (< 500 ml/24h) or creatinine > 135μmol/L, or proteinuria > 5 g/day Pulmonary oedema, epigastric pain or HELLP syndrom (hemolysis, elevated liver enzyme, low platelets) Eclampsia or neurologic persisting symptoms (visual disturbances, headache, increased reflexes) Thrombopenia < 100 G/L Prior caesarean section or uterine scar Placenta praevia Suspected genital herpes infection Known VIH seropositivity (confirmed by blood serology) Premature rupture of membranes (PROM - continual leaking of amniotic fluid or positive test in favour of PROM) Foetus with suspected severe congenital abnormalities Pathological fetal heart rate Contra-indications to Propess® Contra-indications for using Cook® Cervical Ripening Balloon Women under guardianship or trusteeship
Facility Information:
Facility Name
Chu Brest
City
Brest
Country
France
Facility Name
CHU CAEN
City
Caen
ZIP/Postal Code
14033
Country
France
Facility Name
Ch Pontoise
City
Cergy Pontoise
ZIP/Postal Code
95303
Country
France
Facility Name
Ch Chartres
City
Chartres
Country
France
Facility Name
Chu Clermont-Ferrand
City
Clermont-ferrand
ZIP/Postal Code
63001
Country
France
Facility Name
Ch Departemental Vendee
City
La Roche Sur Yon
ZIP/Postal Code
85925
Country
France
Facility Name
Hopital Saint Joseph
City
Marseille
ZIP/Postal Code
13008
Country
France
Facility Name
Chu Nantes
City
Nantes
ZIP/Postal Code
44093
Country
France
Facility Name
Chi Poissy
City
Poissy
Country
France
Facility Name
Chu Reims
City
Reims
ZIP/Postal Code
51092
Country
France
Facility Name
Chu Rennes
City
Rennes
Country
France
Facility Name
Chu Saint Etienne
City
Saint-priest En Jarez
ZIP/Postal Code
42270
Country
France
Facility Name
Chu Toulouse
City
Toulouse
Country
France
Facility Name
Chru Tours
City
Tours
ZIP/Postal Code
37044
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
33571294
Citation
Diguisto C, Le Gouge A, Arthuis C, Winer N, Parant O, Poncelet C, Chauleur C, Hannigsberg J, Ducarme G, Gallot D, Gabriel R, Desbriere R, Beucher G, Faraguet C, Isly H, Rozenberg P, Giraudeau B, Perrotin F; Groupe de Recherche en Obstetrique et Gynecologie (GROG). Cervical ripening in prolonged pregnancies by silicone double balloon catheter versus vaginal dinoprostone slow release system: The MAGPOP randomised controlled trial. PLoS Med. 2021 Feb 11;18(2):e1003448. doi: 10.1371/journal.pmed.1003448. eCollection 2021 Feb.
Results Reference
derived
PubMed Identifier
28912192
Citation
Diguisto C, Le Gouge A, Giraudeau B, Perrotin F. Mechanical cervicAl ripeninG for women with PrOlongedPregnancies (MAGPOP): protocol for a randomised controlled trial of a silicone double balloon catheter versus the Propess system for the slow release of dinoprostone for cervical ripening of prolonged pregnancies. BMJ Open. 2017 Sep 14;7(9):e016069. doi: 10.1136/bmjopen-2017-016069.
Results Reference
derived

Learn more about this trial

Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies

We'll reach out to this number within 24 hrs